Cited by 87Inflammatory Bowel DiseaseOcular Diseases and Behçet’s SyndromePregnancy and Medication Impact

Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry

Bokemeyer, B., Hardt, J., Hüppe, D., Prenzler, A., Conrad, S., Düffelmeyer, M., Hartmann, P., Hoffstadt, M. +5 more·2013·Journal of Crohn s and Colitis

Abstract

BACKGROUND: The aim of this cross-sectional study was to establish an online inflammatory bowel disease (IBD) registry for a first picture of the situation of IBD outpatients' treatment in Germany. METHODS: Between March 2006 and July 2007 IBD outpatients from 24 gastroenterological specialist practices and two hospitals in Germany were enrolled in an Internet-based registry to evaluate the outpatients' clinical status, psychological impairments, provided health care, as well as medical treatment and medication costs. RESULTS: 1032 IBD patients (ulcerative colitis/UC: 519; Crohn's disease/CD: 511; indeterminate colitis: 2) were enrolled in the study (age: 43 ± 14 years/M ± SD). Disease duration of all patients averaged 10 ± 8.5 years. In 519 UC-patients (49% male; 33% pancolitis), 66% were in remission as were 55% of CD patients (37 % male; 41 % active smokers). Associated with higher rates of disease activity (CDAI ≥ 150; CAI>4) were corticosteroids (CD, UC), topical medication (UC), relevant reported depressive symptoms (15%; 6-31%) and impairments in sexuality (21%; 9-42%). Relevant medication groups prescribed were oral aminosalicylates (UC: 70%; CD: 47%); immunosuppressive therapy - mostly azathioprine/6 MP (CD: 47%; UC: 26%), and Infliximab (CD: 8%; UC: 3%). Strongly associated with their clinical disease activity in UC as well as CD patients, 15% (6-31%) reported relevant depressive symptoms and 21% (9-42%) relevant impairments in sexuality. CONCLUSIONS: The registry constitutes a large complemental database for the patient population in Germany. About one third of the IBD patients were not in clinical remission (CDAI ≥150/CAI >4) (CD: 45%; UC: 27%), although high rates of immunosuppressive drugs (CD: 47%; UC 26%) were administered. This study shows a large burden of active disease associated with an unexpectedly high (co)morbidity and high psychosocial impairments, indicating a reduced health state in IBD patients.

Integrity signals

Registry

Crossref · 10.1016/j.crohns.2012.02.014

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A German cross-sectional study including 1,032 IBD patients revealed that relevant reported depressive symptoms correlate with increased rates of disease activity.

    “In contrast, a German cross-sectional study including 1,032 IBD patients, revealed that relevant reported depressive symptoms correlate with increased rates of disease activity (91).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bokemeyer, B., Hardt, J., Hüppe, D., Prenzler, A., Conrad, S., Düffelmeyer, M., Hartmann, P., Hoffstadt, M., Klugmann, T., Schmidt, C., Weismüller, J., Mittendorf, T., & Raspe, H.
Affiliations
  • University Hospital Schleswig-Holstein (DE)
  • University of Wuppertal (DE)
  • Leibniz University Hannover (DE)
  • National Association of Statutory Health Insurance Physicians (DE)
  • University of Lübeck (DE)
Venue
Journal of Crohn s and Colitis
Published
2013-06
Volume
7
Issue
5
Pages
355-368
ISSN
1873-9946 (ISSN-L)
OpenAlex
W2113319332
Cited by
87
References
33
Citations by year
2026: 2 · 2024: 10 · 2023: 8 · 2022: 4 · 2021: 11 · 2020: 4 · 2019: 10 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 4 · 2014: 9 · 2013: 3 · 2012: 1
FWCI
3.28
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Crohn s and Colitis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
inflammatory bowel disease, ulcerative colitis
MeSH terms
Infliximab, Adrenal Cortex Hormones, Adult, Age Factors, Anti-Inflammatory Agents, Non-Steroidal, Antibodies, Monoclonal, C-Reactive Protein, Colitis, Ulcerative, Crohn Disease, Cross-Sectional Studies, Depression, Female, Germany, Humans, Immunosuppressive Agents, Male, Middle Aged, Obesity, Surveys and Questionnaires, Registries, Severity of Illness Index, Sexual Behavior, Sex Factors, Smoking, Time Factors, Drug Costs, Internet

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review